Utility of devices for onychomycosis: a review

References

• Lipner SR. Pharmacotherapy for onychomycosis: new and emerging treatments. Expert Opin Pharmacother. 2019;20(6):1–13. doi: 10.1080/14656566.2019.1571039.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Stec N. Recent advances in therapies for onychomycosis and its management. F1000Res. 2019;8:968. doi: 10.12688/f1000research.18646.1.
   Google Scholar
• Gupta AK, Hall DC, Simkovich AJ. How effective are devices in the management of onychomycosis?: a systematic review. J Am Podiatr Med Assoc. 2023;113(1):21–240.
   PubMedGoogle Scholar
• Gupta AK, Stec N, Summerbell RC, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972–1990. doi: 10.1111/jdv.16394.
   PubMed Web of Science ®Google Scholar
• Falotico JM, Lipner SR. Updated perspectives on the diagnosis and management of onychomycosis. Clin Cosmet Investig Dermatol. 2022;15:1933–1957. doi: 10.2147/CCID.S362635.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Mays RR, Versteeg SG, et al. Global perspectives for the management of onychomycosis. Int J Dermatol. 2019;58(10):1118–1129. doi: 10.1111/ijd.14346.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta G, Jain HC, et al. The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians’ offices. J Eur Acad Dermatol Venereol. 2016;30(9):1567–1572. doi: 10.1111/jdv.13677.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Summerbell RC, Venkataraman M, et al. Nondermatophyte mould onychomycosis. J Eur Acad Dermatol Venereol. 2021;35(8):1628–1641. doi: 10.1111/jdv.17240.
   PubMedGoogle Scholar
• Gupta AK, Versteeg SG, Shear NH. Confirmatory testing prior to initiating onychomycosis therapy is cost-effective. J Cutan Med Surg. 2018;22(2):129–141. doi: 10.1177/1203475417733461.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol. 2014;7:10.
   PubMedGoogle Scholar
• Ebert A, Monod M, Salamin K, et al. Alarming India-wide phenomenon of antifungal resistance in dermatophytes: a multicentre study. Mycoses. 2020;63(7):717–728. doi: 10.1111/myc.13091.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Medical devices and clinical trial design for the treatment or improvement in the appearance of fungally-infected nails guidance for industry and Food and Drug Administration staff preface public comment [Internet]. 2016. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/medical-devices-and-clinical-trial-design-treatment-or-improvement-appearance-fungally-infected.
   Google Scholar
• Abd-Elsalam WH, Abouelatta SM. Contemporary techniques and potential transungual drug delivery nanosystems for the treatment of onychomycosis. AAPS PharmSciTech. 2023;24(6):150. doi: 10.1208/s12249-023-02603-x.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Gianfaldoni S, Tchernev G, Wollina U, et al. An overview of laser in dermatology: the past, the present and … the future (?). Open Access Maced J Med Sci. 2017;5(4):526–530. doi: 10.3889/oamjms.2017.130.
   PubMedGoogle Scholar
• Ma W, Si C, Kasyanju Carrero LM, et al. Laser treatment for onychomycosis: a systematic review and meta-analysis. Medicine. 2019;98(48):e17948. doi: 10.1097/MD.0000000000017948.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Simpson FC, Heller DF. The future of lasers in onychomycosis. J Dermatolog Treat. 2016;27(2):167–172. doi: 10.3109/09546634.2015.1066479.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Simpson FC. Laser therapy for onychomycosis. J Cutan Med Surg. 2013;17(5):301–307. doi: 10.2310/7750.2012.12060.
   PubMed Web of Science ®Google Scholar
• Bhatta AK, Keyal U, Wang X, et al. A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis. Lasers Med Sci. 2017;32(2):469–474. doi: 10.1007/s10103-016-2110-9.
   PubMed Web of Science ®Google Scholar
• Farkas JP, Hoopman JE, Kenkel JM. Five parameters you must understand to master control of your laser/light-based devices. Aesthet Surg J. 2013;33(7):1059–1064. doi: 10.1177/1090820X13501174.
   PubMed Web of Science ®Google Scholar
• Hruza GJ, Dover JS. Laser skin resurfacing. Arch Dermatol. 1996;132(4):451–455. doi: 10.1001/archderm.1996.03890280115016.
   PubMedGoogle Scholar
• Zang K, Sullivan R, Shanks S. A retrospective study of non-thermal laser therapy for the treatment of toenail onychomycosis. J Clin Aesthet Dermatol. 2017;10:24–30.
   PubMedGoogle Scholar
• Paasch U, Mock A, Grunewald S, et al. Antifungal efficacy of lasers against dermatophytes and yeasts in vitro. Int J Hyperthermia. 2013;29(6):544–550. doi: 10.3109/02656736.2013.823672.
   PubMed Web of Science ®Google Scholar
• Carney C, Cantrell W, Warner J, et al. Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser. J Am Acad Dermatol. 2013;69(4):578–582. doi: 10.1016/j.jaad.2013.04.054.
   PubMed Web of Science ®Google Scholar
• Bunyaratavej S, Wanitphakdeedecha R, Ungaksornpairote C, et al. Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment. J Cosmet Dermatol. 2020;19(9):2333–2338. doi: 10.1111/jocd.13291.
   PubMed Web of Science ®Google Scholar
• Sabbah L, Gagnon C, Bernier FE, et al. A randomized, double-blind, controlled trial evaluating the efficacy of Nd: YAG 1064 nm short-pulse laser compared with placebo in the treatment of toenail onychomycosis. J Cutan Med Surg. 2019;23(5):507–512. doi: 10.1177/1203475419861071.
   PubMed Web of Science ®Google Scholar
• Karsai S, Jäger M, Oesterhelt A, et al. Treating onychomycosis with the short-pulsed 1064-nm-Nd: YAG laser: results of a prospective randomized controlled trial. J Eur Acad Dermatol Venereol. 2017;31(1):175–180. doi: 10.1111/jdv.13798.
   PubMed Web of Science ®Google Scholar
• Nijenhuis-Rosien L, Kleefstra N, van Dijk PR, et al. Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1). J Eur Acad Dermatol Venereol. 2019;33(11):2143–2150. doi: 10.1111/jdv.15601.
   PubMed Web of Science ®Google Scholar
• Kim TI, Shin MK, Jeong KH, et al. A randomised comparative study of 1064 nm neodymium-doped yttrium aluminium garnet (Nd: YAG) laser and topical antifungal treatment of onychomycosis. Mycoses. 2016;59(12):803–810. doi: 10.1111/myc.12534.
   PubMed Web of Science ®Google Scholar
• Bashir S, Hassan I, Mubashir S. Carbon dioxide laser plus topical 5% luliconazole: a better combination therapeutic modality for onychomycosis. J Cutan Aesthet Surg. 2021;14:318–322.
   PubMedGoogle Scholar
• Aukstikalnyte AE, Cibien E, De Demo P, et al. Combination of a triple wavelength (650 nm, 810 nm, and 915 nm) class IV laser system and local mechanical abrasion in the treatment of chronic toenail onychomycosis: an uncontrolled prospective pilot study. Int J Dermatol. 2022;61(3):367–371. doi: 10.1111/ijd.15869.
   PubMed Web of Science ®Google Scholar
• El-Tatawy RA, El-Naby NMA, El-Hawary EE, et al. A comparative clinical and mycological study of Nd-YAG laser versus topical terbinafine in the treatment of onychomycosis. J Dermatolog Treat. 2015;26(5):461–464. doi: 10.3109/09546634.2014.998607.
   PubMed Web of Science ®Google Scholar
• Bhatta AK, Keyal U, Wang XL. Photodynamic therapy for onychomycosis: a systematic review. Photodiagnosis Photodyn Ther. 2016;15:228–235. doi: 10.1016/j.pdpdt.2016.07.010.
   PubMed Web of Science ®Google Scholar
• Shen JJ, Jemec GBE, Arendrup MC, et al. Photodynamic therapy treatment of superficial fungal infections: a systematic review. Photodiagnosis Photodyn Ther. 2020;31:101774. doi: 10.1016/j.pdpdt.2020.101774.
   PubMed Web of Science ®Google Scholar
• Sai DL, Lee J, Nguyen DL, et al. Tailoring photosensitive ROS for advanced photodynamic therapy. Exp Mol Med. 2021;53(4):495–504. doi: 10.1038/s12276-021-00599-7.
   PubMed Web of Science ®Google Scholar
• Dai T, Fuchs BB, Coleman JJ, et al. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol. 2012;3:120. doi: 10.3389/fmicb.2012.00120.
   PubMed Web of Science ®Google Scholar
• Boltes Cecatto R, Siqueira de Magalhães L, Fernanda Setúbal Destro Rodrigues M, et al. Methylene blue mediated antimicrobial photodynamic therapy in clinical human studies: the state of the art. Photodiagnosis Photodyn Ther. 2020;31:101828. doi: 10.1016/j.pdpdt.2020.101828.
   PubMed Web of Science ®Google Scholar
• Alberdi E, Gómez C. Urea versus fractional Er: YAG laser pretreatment of methylene blue photodynamic therapy in the treatment of moderate toenail onychomycosis: short- and medium-term effects. Arch Dermatol Res. 2023;315(4):787–794. doi: 10.1007/s00403-022-02448-7.
   PubMed Web of Science ®Google Scholar
• Figueiredo Souza LW, Souza SVT, Botelho ACC. Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis. Dermatol Ther. 2014;27(1):43–47. doi: 10.1111/dth.12042.
   PubMed Web of Science ®Google Scholar
• Gilaberte Y, Robres MP, Frías MP, et al. Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2017;31(2):347–354. doi: 10.1111/jdv.13842.
   PubMed Web of Science ®Google Scholar
• Sobhy N, Talla Eweed H, Omar SS. Fractional CO2 laser - assisted methylene blue photodynamic therapy is a potential alternative therapy for onychomycosis in the era of antifungal resistance. Photodiagnosis Photodyn Ther. 2022;40:103149. doi: 10.1016/j.pdpdt.2022.103149.
   PubMed Web of Science ®Google Scholar
• Alberdi E, Gómez C. Efficiency of methylene blue-mediated photodynamic therapy vs intense pulsed light in the treatment of onychomycosis in the toenails. Photodermatol Photoimmunol Photomed. 2019;35(2):69–77. doi: 10.1111/phpp.12420.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Venkataraman M, Renaud HJ, et al. A paradigm shift in the treatment and management of onychomycosis. Skin Appendage Disord. 2021;7(5):351–358. doi: 10.1159/000516112.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Venkataraman M, Joshi LT, et al. Potential use of microwave technology in dermatology. J Dermatolog Treat. 2022;33(7):2899–2910. doi: 10.1080/09546634.2022.2089333.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Hall DC, Simkovich AJ. How effective are devices in the management of onychomycosis? A systematic review. J Am Podiatr Med Assoc. 2023;113(1)doi: 10.7547/21-240.
   PubMedGoogle Scholar
• Strauss R. Microwave oven [Internet]. Smithsonian Snapshot; 2013 [cited 2023 May 22]. Available from: https://www.si.edu/newsdesk/snapshot/microwave-oven.
   Google Scholar
• Shaw P, Kumar N, Mumtaz S, et al. Evaluation of non-thermal effect of microwave radiation and its mode of action in bacterial cell inactivation. Sci Rep. 2021;11(1):14003. doi: 10.1038/s41598-021-93274-w.
   PubMed Web of Science ®Google Scholar
• Deng X, Huang H, Huang S, et al. Insight into the incredible effects of microwave heating: driving changes in the structure, properties and functions of macromolecular nutrients in novel food. Front Nutr. 2022;9:941527. doi: 10.3389/fnut.2022.941527.
   PubMed Web of Science ®Google Scholar
• Beale G, McErlean E, Kidd M, et al. Treatment of fungal infections 2022 emblation patent [Internet]. USA; 2022. p. 1–12. Available from: https://patentimages.storage.googleapis.com/66/8c/25/f44def8c5e006d/US20220219007A1.pdf.
   Google Scholar
• Ahmed LT, Majeed AD, Salhi A. The effect of mobile waves on the growth of pathogenic fungi. IntJCurrMicrobiolAppSci. 2015;4:838–842.
   Google Scholar
• Budihardja D, Mayser P. The effect of microwave irradiation on the vitality of various dermatophytes. Mycoses. 2014;57(4):209–213. doi: 10.1111/myc.12144.
   PubMed Web of Science ®Google Scholar
• A. Al-Mayah A, T. Ali E. Mobile microwave effect on bacterial antibiotic sensitivity. Bas.J.Vet.Res. 2010;9(2):89–102. doi: 10.33762/bvetr.2010.55052.
   Google Scholar
• López M, Calvo T, Prieto M, et al. A review on non-thermal atmospheric plasma for food preservation: mode of action, determinants of effectiveness, and applications. Front Microbiol. 2019;10:622. doi: 10.3389/fmicb.2019.00622.
   PubMed Web of Science ®Google Scholar
• Conrads H, Schmidt M. Plasma generation and plasma sources. Plasma Sources Sci. Technol. 2000;9(4):441–454. doi: 10.1088/0963-0252/9/4/301.
   Web of Science ®Google Scholar
• Molokov S, Moreau R, Moffatt HK. Magnetohydrodynamics: historical evolution and trends. In: Molokov S, Moreau R, Moffatt HK, editors. Dordecht: Springer; 2007.
   Google Scholar
• Neyts EC, Bogaerts A. Understanding plasma catalysis through modelling and simulation – a review. J Phys D Appl Phys. 2014;47(22):224010.
   Web of Science ®Google Scholar
• Sherman A. Magnetohydrodynamic channel flows with nonequilibrium ionization. Physics of Fluids. 1966;9(9):1782–1787. doi: 10.1063/1.1761933.
   Web of Science ®Google Scholar
• Kar R, Chand N, Bute A, et al. Cold plasma: clean technology to destroy pathogenic micro-organisms. Trans Indian Natl Acad Eng. 2020;5(2):327–331. doi: 10.1007/s41403-020-00133-7.
   Google Scholar
• Laroussi M. Sterilization of contaminated matter with an atmospheric pressure plasma. IEEE Trans Plasma Sci. 1996;24(3):1188–1191. doi: 10.1109/27.533129.
   Web of Science ®Google Scholar
• Wende K, Nasri Z, Striesow J, et al. Is biomolecule oxidation by plasma-derived reactive species restricted to the Gas-Liquid interphase? 2022 IEEE International Conference on Plasma Science (ICOPS); 2022. p. 1–2.
   Google Scholar
• Ahmadi M, Potlitz F, Link A, et al. Flucytosine-based prodrug activation by cold physical plasma. Arch Pharm. 2022;355(9):e2200061. doi: 10.1002/ardp.202200061.
   PubMed Web of Science ®Google Scholar
• Nasri Z, Memari S, Wenske S, et al. Singlet-Oxygen-Induced phospholipase A2 inhibition: a major role for interfacial tryptophan dioxidation. Chemistry. 2021;27(59):14702–14710. doi: 10.1002/chem.202102306.
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Nasri Z, Von Woedtke T, et al. D -Glucose oxidation by cold atmospheric plasma-induced reactive species. ACS Omega. 2022;7(36):31983–31998. doi: 10.1021/acsomega.2c02965.
   PubMed Web of Science ®Google Scholar
• Hoppanová L, Kryštofová S. Nonthermal plasma effects on fungi: applications, fungal responses, and future perspectives. Int J Mol Sci. 2022;23(19):11592. doi: 10.3390/ijms231911592.
   PubMed Web of Science ®Google Scholar
• Ehlbeck J, Schnabel U, Polak M, et al. Low temperature atmospheric pressure plasma sources for microbial decontamination. J Phys D Appl Phys. 2011;44(1):013002. doi: 10.1088/0022-3727/44/1/013002.
   Web of Science ®Google Scholar
• Misra NN, Yadav B, Roopesh MS, et al. Cold plasma for effective fungal and mycotoxin control in foods: mechanisms, inactivation effects, and applications. Compr Rev Food Sci Food Saf. 2019;18(1):106–120. doi: 10.1111/1541-4337.12398.
   PubMed Web of Science ®Google Scholar
• Heinlin J, Maisch T, Zimmermann JL, et al. Contact-free inactivation of Trichophyton rubrum and microsporum canis by cold atmospheric plasma treatment. Future Microbiol. 2013;8(9):1097–1106. doi: 10.2217/fmb.13.86.
   PubMed Web of Science ®Google Scholar
• Lipner SR, Friedman G, Scher RK. Pilot study to evaluate a plasma device for the treatment of onychomycosis. Clin Exp Dermatol. 2017;42(3):295–298. doi: 10.1111/ced.12973.
   PubMed Web of Science ®Google Scholar
• Terabe Y, Kaneko N, Ando H. Treating hard-to-heal skin and nail onychomycosis of diabetic foot with plasma therapy. Dermatol Ther. 2021;34:e15127.
   PubMed Web of Science ®Google Scholar
• Hao J, Smith KA, Li SK. Iontophoretically enhanced ciclopirox delivery into and across human nail plate. J Pharm Sci. 2009;98(10):3608–3616. doi: 10.1002/jps.21664.
   PubMed Web of Science ®Google Scholar
• Helmstadtler A. The history of electrically-assisted transdermal drug delivery (iontophoresis). Pharmazie. 2001;56:583–587.
   PubMed Web of Science ®Google Scholar
• Glaser RW, Leikin SL, Chernomordik LV, et al. Reversible electrical breakdown of lipid bilayers: formation and evolution of pores. Biochim Biophys Acta. 1988;940(2):275–287. doi: 10.1016/0005-2736(88)90202-7.
   PubMedGoogle Scholar
• Chizmadzhev YA, Indenbom AV, Kuzmin PI, et al. Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J. 1998;74(2 Pt 1):843–856. doi: 10.1016/S0006-3495(98)74008-1.
   PubMed Web of Science ®Google Scholar
• Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev. 2001;46(1–3):281–305. doi: 10.1016/s0169-409x(00)00138-1.
   PubMed Web of Science ®Google Scholar
• Kasting GB. Theoretical models for iontophoretic delivery. Adv Drug Deliv Rev. 1992;9(2):177–199.
   Web of Science ®Google Scholar
• Gupta AK, Polla Ravi S, Choi SY, et al. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis. J Eur Acad Dermatol Venereol. 2023;37(2):243–255. doi: 10.1111/jdv.18638.
   PubMedGoogle Scholar
• Murthy SN, Wiskirchen DE, Bowers CP. Iontophoretic drug delivery across human nail. J Pharm Sci. 2007;96(2):305–311. doi: 10.1002/jps.20757.
   PubMed Web of Science ®Google Scholar
• Amichai B, Nitzan B, Mosckovitz R, et al. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. Br J Dermatol. 2010;162(1):46–50. doi: 10.1111/j.1365-2133.2009.09414.x.
   PubMed Web of Science ®Google Scholar
• Dutet J, Delgado-Charro B. Electroosmotic transport of mannitol across human nail during constant current iontophoresis. J Pharm Pharmacol. 2010;62(6):721–729. doi: 10.1211/jpp.62.06.0008.
   PubMed Web of Science ®Google Scholar
• Nair AB, Vaka SRK, Sammeta SM, et al. Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci. 2009;98(5):1788–1796. doi: 10.1002/jps.21555.
   PubMed Web of Science ®Google Scholar
• Samhan AF, Abdelhalim NM. Terbinafine hydrochloride 1% iontophoresis for the treatment of toenail onychomycosis: a randomized placebo controlled study. J Nov Physiother. 2015;05(02):1–6. doi: 10.4172/2165-7025.1000252.
   Google Scholar
• Díaz DC, Iglesias MEL, Vallejo Rb de B, et al. Transungual delivery of ciclopirox is increased 3–4-fold by mechanical fenestration of human nail plate in an in vitro model. Pharmaceutics. 2019;11:29.
   PubMed Web of Science ®Google Scholar
• Shemer A, Gupta A, Amichai B, et al. An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis. J Dermatolog Treat. 2016;27(5):480–483. doi: 10.3109/09546634.2016.1151856.
   PubMed Web of Science ®Google Scholar
• Sumikawa M, Egawa T, Honda I, et al. Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis. J Dermatol. 2007;34(7):456–464. doi: 10.1111/j.1346-8138.2007.00310.x.
   PubMed Web of Science ®Google Scholar
• Newman PG, Rozycki GS. The history of ultrasound. Surg Clin North Am. 1998;78(2):179–195. doi: 10.1016/s0039-6109(05)70308-x.
   PubMed Web of Science ®Google Scholar
• Sun Y, Xiong X, Pandya D, et al. Enhancing tissue permeability with MRI guided preclinical focused ultrasound system in rabbit muscle: from normal tissue to VX2 tumor. J Control Release. 2017;256:1–8. doi: 10.1016/j.jconrel.2017.04.017.
   PubMed Web of Science ®Google Scholar
• Thakkar D, Gupta R, Monson K, et al. Effect of ultrasound on the permeability of vascular wall to nano-emulsion droplets. Ultrasound Med Biol. 2013;39(10):1804–1811. doi: 10.1016/j.ultrasmedbio.2013.04.008.
   PubMed Web of Science ®Google Scholar
• Mcmahon D, Bendayan R, Hynynen K. Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome. Sci Rep. 2017;7(1):45657. doi: 10.1038/srep45657.
   PubMedGoogle Scholar
• Duan L, Yang L, Jin J, et al. Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications. Theranostics. 2020;10(2):462–483. doi: 10.7150/thno.37593.
   PubMed Web of Science ®Google Scholar
• Kline-Schoder A, Le Z, Liam Sweeney D, et al. Optimization of Ultrasound-Mediated drug delivery for treatment of onychomycosis. J Am Podiatr Med Assoc. 2019. doi: 10.7547/18-084.
   PubMedGoogle Scholar
• Kline-Schoder A, Le Z, Zderic V. Ultrasound-enhanced drug delivery for treatment of onychomycosis. J Ultrasound Med. 2018;37(7):1743–1752. doi: 10.1002/jum.14526.
   PubMed Web of Science ®Google Scholar
• Loh B-G, Hyun S, Ro PI, et al. Acoustic streaming induced by ultrasonic flexural vibrations and associated enhancement of convective heat transfer. J Acoust Soc Am. 2002;111(2):875–883. doi: 10.1121/1.1433811.
   PubMed Web of Science ®Google Scholar
• Abadi D, Zderic V. Ultrasound-Mediated nail drug delivery system. J Ultrasound Med. 2011;30(12):1723–1730. doi: 10.7863/jum.2011.30.12.1723.
   PubMed Web of Science ®Google Scholar
• Kline-Schoder A, Le Z, Zderic V. Ultrasound-Enhanced ciclopirox delivery for treatment of onychomycosis. Annu Int Conf IEEE Eng Med Biol Soc. 2018;2018:5717–5720. doi: 10.1109/EMBC.2018.8513552.
   PubMedGoogle Scholar